title: The FDA and ECT.
authors.affiliation: From the *Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA; †Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC; Departments of ‡Psychiatry, §Pharmacological Sciences, and ‖Biomedical Informatics, Stony Brook University School of Medicine, Stony Brook, NY; and ¶Department of Psychiatry and Health Behavior, Medical College of Georgia at Augusta University, Augusta, GA.
authors.forename: William M
authors.initials: WM
authors.lastname: McDonald
authors.forename: Richard D
authors.initials: RD
authors.lastname: Weiner
authors.forename: Laura J
authors.initials: LJ
authors.lastname: Fochtmann
authors.forename: W Vaughn
authors.initials: WV
authors.lastname: McCall
mesh_terms: D004565:Electroconvulsive Therapy / Q000295:instrumentation* / Q000331:legislation & jurisprudence*; D006801:Humans; D001523:Mental Disorders / Q000628:therapy; D011356:Product Labeling / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*